Clinical Cancer Genomics conference, March 20-21 2025, Amsterdam
We are pleased to announce that registration for this novel exciting meeting focused on cancer whole genome and transcriptome sequencing in a clinical setting, is now open. Please visit www.ccg2025.eu for more information, abstract submission or registration of your participation!
An increasing number of European countries are adapting clinical cancer (gen)omics programs including whole genome and transcriptome sequencing (WGTS) to enable cancer precision medicine and support research and a learning health care system for improving future cancer care.
This meeting will be the first of an annual recurring series and aims to bring together researchers and medical specialists involved in these programs or interested in genomics-based and data-driven cancer care and/or research. The current state-of-the-art implementations in routine care, research highlights, clinical impact and future developments will be presented and discussed.
National programs in Europe supporting translation of genomics approaches from the clinic to research and back will be central to this meeting. The first meeting will take place on Thursday March 20 and Friday 21, 2025 in Amsterdam, the Netherlands, and is initiated as part of the 10th anniversary of Hartwig Medical Foundation. The meeting will be organised together with Genomics England, DKFZ German Cancer Research Center MASTER/NCT, Genomic Medicine Sweden, Plan France Médecine Génomique 2025 , and Danish National Genome Center.
All news
Also read
Unique insights in the differences between primary and metastatic cancer by large-scale DNA data analyses
Researchers have obtained valuable insights into the development of tumors from a unique Dutch data collection. These insights provide relevant …
To study rare cancers, collaboration is key
In honor of Rare Disease Day on February 28th, we spoke with Professor Stefan Fröhling about his research on rare …
Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs
The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer …
The number of WGS samples Hartwig Medical Foundation has is quite unique in the research field and is rapidly growing. It amounted to 3.500 samples when we started and it’s already over 5.000 now.